• Paul H Stypulkowski, Scott R Stanslaski, Timothy J Denison, and Jonathon E Giftakis.
• Medtronic Neuromodulation, Minneapolis, MN 55432, USA. paul.stypulkowski@medtronic.com
• Stereotact Funct Neurosurg. 2013 Jan 1; 91 (4): 220-32.

Background/AimsIn conjunction with therapeutic stimulation, next-generation deep brain stimulation (DBS) devices may offer the ability to record and analyze neural signals, providing for unprecedented insight into DBS effects on neural networks. This work was conducted to evaluate an implantable, clinical-grade system that permits concurrent stimulation and recording using a large animal (ovine) model recently developed to study DBS for epilepsy.MethodsFollowing anesthesia and 1.5-tesla MRI acquisition, unilateral anterior thalamic and hippocampal DBS leads were implanted (n = 3) using a frameless stereotactic system. Chronic, awake recordings of evoked potentials (EPs) and local field potentials were collected with the implanted device and analyzed off-line.ResultsHippocampal EPs were stable over long-term (>1 year) recording and consistent in morphology and latency with prior acute results. Thalamic and hippocampal DBS produced both excitatory and inhibitory network effects that were stimulation site and parameter dependent. Free roaming recordings illustrated periods of highly correlated activity between these two structures within the circuit of Papez.ConclusionsThese results provide further insight into mechanisms of DBS therapy for epilepsy and an encouraging demonstration of the capabilities of this new technology, which in the future, may afford unique opportunities to study human brain function and neuromodulation mechanism of action.Copyright © 2013 S. Karger AG, Basel.

20 keywords...

hide…